HOME › DRUGS › LUTETIUM (177LU) OXODOTREOTIDE
ACTIVE SUBSTANCE / INN

LUTETIUM (177LU) OXODOTREOTIDE

Brand name(s): Lutathera
EMA LISTED
AUTHORISED
Neuroendocrine Tumors
ACTIVE SUBSTANCE
Lutetium (177Lu) Oxodotreotide
REGULATORS
EMA
SPONSORS / MAH
Advanced Accelerator Applications
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LutatheraAdvanced Accelerator ApplicationsAuthorised26/09/2017Neuroendocrine Tumors

FULL INTELLIGENCE ON LUTETIUM (177LU) OXODOTREOTIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →